Pfizer vows to fight ‘perverse and short-sighted decision’ on Exubera
April 24, 2006Research and Development
Exubera, the world's first inhaled insulin, has failed to gain NICE approval after manufacturer Pfizer couldnt convince the Institute of …
Lipitor remains England’s biggest seller
April 24, 2006Sales and Marketing
New figures for pharmaceutical sales in England and the rest of the world see the industry continuing to maintain growth, …
GSK unveils first of new virtual pipeline drug discovery alliances
April 24, 2006Research and Development
Pharmacopeia, a small New Jersey pharmaceutical company will be the first to enter into a new kind of drug development …
Industry warns of worrying signs from NHS drugs bill
April 13, 2006NHS spending on medicines has fallen in relation to its overall budget – just one of the many causes of …
Herceptin court victory for breast cancer patient
April 13, 2006Sales and Marketing
Ann Marie Rogers has won her legal battle to gain access to breast cancer drug Herceptin, with an appeal court …
New marker points in the right direction for GSK heart drug
April 13, 2006New research suggests a little-understood chemical in the human body could play a key role in causing heart attacks and …
Patients fight NICE over cancer fatigue drugs
April 12, 2006Sales and Marketing
Patient groups are fighting to keep drugs available on the NHS, which they say help cancer patients recover after chemotherapy.NICE …
Restructure will cut costs and improve NHS services, says Hewitt
April 12, 2006Hewitt, NHS
Health secretary Patricia Hewitt, has unveiled a map of the new NHS ‘architecture’, which she says will reduce NHS costs …
Remicade to treat ulcerative colitis in UK
April 12, 2006Sales and Marketing
Patients in the UK with ulcerative colitis could benefit from Remicade, the first new drug in years to be approved …
Wyeth to collaborate with Scottish universities on biomarkers
April 11, 2006Research and Development
Wyeth is to invest $86 million in a new collaboration with Scotland's leading medical researchers in a cutting edge area …
New GP surgery openings ‘quicker than Tesco’
April 10, 2006The government says dozens of new GP surgeries will be opened over the next three years, bringing a broad range …
Fears for UK clinical trials as antibody inquiry proceeds
April 10, 2006Research and Development
The MHRA is to put together an expert group to examine the need for new safety measures in the wake …
Is Talent Unstoppable?
April 7, 2006Business Services
A sales manager's job is not to grow sales – it is to grow successful sales people. Forget the days …
Lyrica to challenge antidepressants with new anxiety disorder approval
April 7, 2006Research and Development
Pfizer's Lyrica is to go head to head with top-selling antidepressant drugs as it enters the market to treat generalised …
NHS lurches into new financial year with old debts and new challenges
April 7, 2006The NHS has begun a new financial year amid considerable acrimony and massive disruption as many of its trusts grapple …
Novartis launch innovative leukaemia awareness campaign
March 30, 2006Research and Development
Novartis has launched an innovative new campaign to raise awareness of leukaemia treatment among the UK's general practitioners; a move …
Novartis to develop Servier’s antidepressant for US
March 30, 2006Research and Development
Novartis has signed a deal to develop and market Servier's new antidepressant and agomelatine for the US market.The drug has …
Novartis targets China with hepatitis drug
March 30, 2006Research and Development
Novartis says trials of its new hepatitis drug in Chinese patients show it to be superior to standard treatment, in …
Taxotere approved for stomach cancer in US
March 28, 2006Research and Development
Sanofi-Aventis has won US approval to market its drug Taxotere as a treatment for stomach cancer, and says it is …
Nearly half of doctors unaware of industry Code of Practice
March 28, 2006Sales and Marketing
Nearly half of all doctors are unaware that the UK pharmaceutical industry operates a code of practice, a new survey …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
